GT BIOPHARMA INC's ticker is GTBP and the CUSIP is 36254L209. A total of 22 filers reported holding GT BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $0 | -100.0% | 2,436 | -36.2% | 0.00% | – |
Q2 2023 | $2,000 | +100.0% | 3,819 | +52.3% | 0.00% | – |
Q1 2023 | $1,000 | -99.6% | 2,508 | -99.1% | 0.00% | – |
Q4 2022 | $250,000 | +8233.3% | 281,958 | +13534.3% | 0.00% | – |
Q3 2022 | $3,000 | -50.0% | 2,068 | +5.6% | 0.00% | – |
Q2 2022 | $6,000 | -33.3% | 1,958 | -35.8% | 0.00% | – |
Q1 2022 | $9,000 | -55.0% | 3,049 | -52.2% | 0.00% | – |
Q4 2021 | $20,000 | -28.6% | 6,377 | +54.3% | 0.00% | – |
Q3 2021 | $28,000 | -49.1% | 4,134 | +15.2% | 0.00% | – |
Q2 2021 | $55,000 | -67.1% | 3,590 | -85.4% | 0.00% | – |
Q1 2021 | $167,000 | – | 24,542 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baskin Financial Services Inc. | 151,354 | $36 | 0.00% |
Moss Adams Wealth Advisors LLC | 20,000 | $4,822 | 0.00% |
UBS Group AG | 8,750 | $2,109 | 0.00% |
Compagnie Lombard Odier SCmA | 50,000 | $12,055 | 0.00% |
OSAIC HOLDINGS, INC. | 1,270 | $305 | 0.00% |
FMR LLC | 150 | $36 | 0.00% |
BANK OF AMERICA CORP /DE/ | 508 | $122 | 0.00% |
WELLS FARGO & COMPANY/MN | 300,697 | $72,498 | 0.00% |
NORTHERN TRUST CORP | 32,347 | $7,799 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |